COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia

Cancer Cell. 2022 Jun 13;40(6):584-586. doi: 10.1016/j.ccell.2022.05.001. Epub 2022 May 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Immunity, Cellular
  • Leukemia, Lymphocytic, Chronic, B-Cell*

Substances

  • COVID-19 Vaccines